BRIAN B HANSEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRIAN B HANSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRIAN B HANSEN. BRIAN B HANSEN is SVP, Global Sales & Service in GEN PROBE INC ($GPRO) and EVP & CHIEF COMMERCIAL OFFICER in TANDEM DIABETES CARE INC ($TNDM).
Latest Insider Trading Transactions of BRIAN B HANSEN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 81.63 | 7,940 | 648,142 | 7,940 | |
| May 20 2021 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 0.00 | 2,599 | 0 | 2,599 | |
| May 20 2021 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 0.00 | 2,599 | 0 | 2,599 | |
| May 20 2021 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 66.76 | 296 | 19,761 | 4,961 | 4.7 K to 5 K (+6.35 %) |
| Sep 30 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 51.50 | 4,489 | 231,184 | 85,000 | |
| Sep 30 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 112.75 | 4,489 | 506,135 | 4,665 | 9.2 K to 4.7 K (-49.04 %) |
| Sep 30 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 51.50 | 4,489 | 231,184 | 9,154 | 4.7 K to 9.2 K (+96.23 %) |
| Sep 30 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 51.50 | 4,489 | 231,184 | 85,000 | |
| Sep 30 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 112.75 | 4,489 | 506,135 | 4,665 | 9.2 K to 4.7 K (-49.04 %) |
| Sep 30 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 51.50 | 4,489 | 231,184 | 9,154 | 4.7 K to 9.2 K (+96.23 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 51.50 | 10,525 | 542,038 | 89,489 | |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 114.03 | 1,111 | 126,688 | 4,665 | 5.8 K to 4.7 K (-19.23 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 112.88 | 9,414 | 1,062,640 | 5,776 | 15.2 K to 5.8 K (-61.97 %) |
| Sep 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 51.50 | 10,525 | 542,038 | 15,190 | 4.7 K to 15.2 K (+225.62 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 51.50 | 4,986 | 256,779 | 100,014 | |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 18.86 | 25,000 | 471,500 | 0 | |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 69.50 | 9,146 | 635,647 | 0 | |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 112.89 | 4,986 | 562,859 | 4,665 | 9.7 K to 4.7 K (-51.66 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 51.50 | 4,986 | 256,779 | 9,651 | 4.7 K to 9.7 K (+106.88 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 112.18 | 200 | 22,436 | 4,665 | 4.9 K to 4.7 K (-4.11 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 111.48 | 23,731 | 2,645,451 | 4,865 | 28.6 K to 4.9 K (-82.99 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 110.32 | 10,215 | 1,126,958 | 28,596 | 38.8 K to 28.6 K (-26.32 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 25,000 | 471,500 | 38,811 | 13.8 K to 38.8 K (+181.02 %) |
| Sep 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 69.50 | 9,146 | 635,647 | 13,811 | 4.7 K to 13.8 K (+196.06 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 9.00 | 8,320 | 74,880 | 2,180 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 69.50 | 4,354 | 302,603 | 9,146 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 23.00 | 11,280 | 259,440 | 0 | |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 106.11 | 8,320 | 882,809 | 4,665 | 13 K to 4.7 K (-64.07 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 9.00 | 8,320 | 74,880 | 12,985 | 4.7 K to 13 K (+178.35 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 106.55 | 4,354 | 463,913 | 4,665 | 9 K to 4.7 K (-48.28 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 69.50 | 4,354 | 302,603 | 9,019 | 4.7 K to 9 K (+93.33 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 105.99 | 3,400 | 360,352 | 4,665 | 8.1 K to 4.7 K (-42.16 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 23.00 | 3,400 | 78,200 | 8,065 | 4.7 K to 8.1 K (+72.88 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 105.16 | 7,880 | 828,690 | 4,665 | 12.5 K to 4.7 K (-62.81 %) |
| Aug 04 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 23.00 | 7,880 | 181,240 | 12,545 | 4.7 K to 12.5 K (+168.92 %) |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 82.34 | 15,012 | 1,236,088 | 15,012 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 0.00 | 6,504 | 0 | 6,504 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 82.34 | 15,012 | 1,236,088 | 15,012 | |
| May 29 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 0.00 | 6,504 | 0 | 6,504 | |
| May 19 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 16.93 | 1,255 | 21,247 | 4,665 | 3.4 K to 4.7 K (+36.80 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 77.62 | 20,945 | 1,625,652 | 2,991 | 23.9 K to 3 K (-87.50 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 20,945 | 395,023 | 23,936 | 3 K to 23.9 K (+700.27 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 72.78 | 10,000 | 727,842 | 2,991 | 13 K to 3 K (-76.98 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 10,000 | 188,600 | 12,991 | 3 K to 13 K (+334.34 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 74.82 | 15,000 | 1,122,300 | 2,991 | 18 K to 3 K (-83.38 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 15,000 | 282,900 | 17,991 | 3 K to 18 K (+501.50 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 77.51 | 4,055 | 314,303 | 2,991 | 7 K to 3 K (-57.55 %) |
| Jan 31 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 4,055 | 76,477 | 7,046 | 3 K to 7 K (+135.57 %) |
| Jan 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
| Jan 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 69.76 | 10,000 | 697,620 | 2,991 | 13 K to 3 K (-76.98 %) |
| Jan 17 2020 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 0.00 | 10,000 | 0 | 12,991 | 3 K to 13 K (+334.34 %) |
| Nov 06 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 15,000 | 38,850 | 10,000 | |
| Nov 06 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 62.01 | 15,000 | 930,131 | 2,991 | 18 K to 3 K (-83.38 %) |
| Nov 06 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 2.59 | 15,000 | 38,850 | 17,991 | 3 K to 18 K (+501.50 %) |
| Aug 28 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 18.86 | 6,969 | 131,435 | 75,000 | |
| Aug 28 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 70.00 | 6,969 | 487,830 | 2,991 | 10 K to 3 K (-69.97 %) |
| Aug 28 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 6,969 | 131,435 | 9,960 | 3 K to 10 K (+233.00 %) |
| Aug 13 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 15,000 | 38,850 | 25,000 | |
| Aug 13 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 62.97 | 15,000 | 944,550 | 2,991 | 18 K to 3 K (-83.38 %) |
| Aug 13 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 2.59 | 15,000 | 38,850 | 17,991 | 3 K to 18 K (+501.50 %) |
| Aug 13 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 15,000 | 38,850 | 25,000 | |
| Aug 13 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 62.97 | 15,000 | 944,550 | 2,991 | 18 K to 3 K (-83.38 %) |
| Aug 13 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 2.59 | 15,000 | 38,850 | 17,991 | 3 K to 18 K (+501.50 %) |
| Jul 12 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 18.86 | 13,031 | 245,765 | 86,969 | |
| Jul 12 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 70.04 | 13,031 | 912,691 | 2,991 | 16 K to 3 K (-81.33 %) |
| Jul 12 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 18.86 | 13,031 | 245,765 | 16,022 | 3 K to 16 K (+435.67 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 16.93 | 1,610 | 27,257 | 2,991 | 1.4 K to 3 K (+116.58 %) |
| May 17 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 16.93 | 1,610 | 27,257 | 2,991 | 1.4 K to 3 K (+116.58 %) |
| Mar 15 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 10,000 | 25,900 | 40,000 | |
| Mar 15 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 72.00 | 10,000 | 720,000 | 1,381 | 11.4 K to 1.4 K (-87.87 %) |
| Mar 15 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 2.59 | 10,000 | 25,900 | 11,381 | 1.4 K to 11.4 K (+724.11 %) |
| Feb 20 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 51.50 | 105,000 | 5,407,500 | 105,000 | |
| Jan 15 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 25,000 | 64,750 | 50,000 | |
| Jan 15 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 41.54 | 25,000 | 1,038,528 | 1,381 | 26.4 K to 1.4 K (-94.77 %) |
| Jan 15 2019 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 2.59 | 25,000 | 64,750 | 26,381 | 1.4 K to 26.4 K (+1,810.28 %) |
| Dec 13 2018 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | M | 2.59 | 25,000 | 64,750 | 75,000 | |
| Dec 13 2018 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Sell | S | 37.75 | 25,000 | 943,750 | 1,381 | 26.4 K to 1.4 K (-94.77 %) |
| Dec 13 2018 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Buy | M | 2.59 | 25,000 | 64,750 | 26,381 | 1.4 K to 26.4 K (+1,810.28 %) |
| Nov 19 2018 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 16.92 | 482 | 8,155 | 1,381 | 899 to 1.4 K (+53.62 %) |
| Jun 15 2018 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 18.86 | 100,000 | 1,886,000 | 100,000 | |
| Dec 05 2017 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 2.59 | 100,000 | 259,000 | 100,000 | |
| May 18 2017 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 0.90 | 105,000 | 94,500 | 105,000 | |
| May 18 2017 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 0.77 | 5,303 | 4,083 | 8,974 | 3.7 K to 9 K (+144.46 %) |
| Dec 16 2016 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 2.30 | 112,800 | 259,440 | 112,800 | |
| Nov 16 2016 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Grant | A | 1.62 | 3,671 | 5,947 | 3,671 | 0 to 3.7 K |
| Feb 29 2016 | TNDM | TANDEM DIABETES CA ... | HANSEN BRIAN B | EVP & CHIEF COMMERC ... | Option Exercise | A | 6.95 | 135,000 | 938,250 | 135,000 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 0.00 | 6,816 | 0 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 0.00 | 363 | 0 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 0.00 | 1,087 | 0 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 69.22 | 16,623 | 1,150,644 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 62.50 | 3,188 | 199,250 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 63.80 | 9,563 | 610,119 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 42.66 | 16,313 | 695,913 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 38.51 | 7,350 | 283,049 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 60.15 | 13,000 | 781,950 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 60.82 | 16,000 | 973,120 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | D | 48.79 | 9,350 | 456,187 | 0 | |
| Aug 02 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Sell | D | 82.75 | 8,584 | 710,326 | 0 | 8.6 K to 0 (-100.00 %) |
| Feb 24 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | M | 0.00 | 214 | 0 | 363 | |
| Feb 24 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | A | 0.00 | 34 | 0 | 577 | |
| Feb 24 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Payment of Exercise | F | 68.18 | 71 | 4,841 | 8,584 | 8.7 K to 8.6 K (-0.82 %) |
| Feb 24 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Buy | M | 0.00 | 214 | 0 | 8,655 | 8.4 K to 8.7 K (+2.54 %) |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | M | 0.00 | 644 | 0 | 1,087 | |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | A | 0.00 | 102 | 0 | 1,731 | |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Payment of Exercise | F | 69.22 | 147 | 10,175 | 8,441 | 8.6 K to 8.4 K (-1.71 %) |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Payment of Exercise | F | 69.22 | 245 | 16,959 | 8,588 | 8.8 K to 8.6 K (-2.77 %) |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Buy | M | 0.00 | 644 | 0 | 8,833 | 8.2 K to 8.8 K (+7.86 %) |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | A | 0.00 | 6,816 | 0 | 6,816 | |
| Feb 16 2012 | GPRO | GEN PROBE INC | HANSEN BRIAN B | SVP, Global Sales & ... | Option Exercise | A | 69.22 | 16,623 | 1,150,644 | 16,623 |
Page: 1